DA
Denali Advisors Portfolio holdings
AUM
$960M
1-Year Return
20.62%
This Quarter Return
+2.12%
1 Year Return
+20.62%
3 Year Return
+77.88%
5 Year Return
+175.56%
10 Year Return
+248.86%
AUM
$240M
AUM Growth
+$1.82M
(+0.76%)
Cap. Flow
-$536K
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
502
New
87
Increased
141
Reduced
104
Closed
66
Top Buys
| 1 |
Victory Capital Holdings
VCTR
|
$2.13M |
| 2 |
Sylvamo
SLVM
|
$1.9M |
| 3 |
Essent Group
ESNT
|
$1.79M |
| 4 |
Jackson Financial
JXN
|
$1.78M |
| 5 |
Boise Cascade
BCC
|
$1.56M |
Top Sells
| 1 |
NBT Bancorp
NBTB
|
$3.59M |
| 2 |
PennyMac Financial
PFSI
|
$3.09M |
| 3 |
LCI Industries
LCII
|
$2.89M |
| 4 |
Acushnet Holdings
GOLF
|
$2.65M |
| 5 |
Otter Tail
OTTR
|
$2.59M |
Sector Composition
| 1 | Financials | 31.47% |
| 2 | Industrials | 13.54% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Consumer Staples | 10% |
| 5 | Real Estate | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Silvercrest Asset Management
SAMG
$134M
| $47.3K | 0.02% |
2,600
| – | – |
|
227
Prelude Therapeutics
PRLD
$69.6M
| $46.7K | 0.02% |
8,200
| – | – |
|
228
Home Bancorp
HBCP
$440M
| $46.2K | 0.02% |
1,400
| – | – |
|
229
KalVista Pharmaceuticals
KALV
$796M
| $45.6K | 0.02% |
5,800
-5,000
| -46% | -$39.3K |
|
230
Generation Bio
GBIO
$40.3M
| $45.6K | 0.02% |
1,060
| – | – |
|
231
IDT Corp
IDT
$1.64B
| $44.3K | 0.02% |
1,300
| – | – |
|
232
Kimball Electronics
KE
$724M
| $43.4K | 0.02% |
1,800
| – | – |
|
233
RBB Bancorp
RBB
$343M
| $41.9K | 0.02% |
2,700
-4,200
| -61% | -$65.1K |
|
234
Y-mAbs Therapeutics
YMAB
$390M
| $41.6K | 0.02% |
+8,300
| New | +$41.6K |
|
235
REX American Resources
REX
$1.02B
| $40.6K | 0.02% |
1,421
+1,400
| +6,667% | +$40K |
|
236
Sensus Healthcare
SRTS
$53.1M
| $39.6K | 0.02% |
7,600
| – | – |
|
237
NRG Energy
NRG
$28.6B
| $39.4K | 0.02% |
1,148
-8,486
| -88% | -$291K |
|
238
Value Line
VALU
$346M
| $38.7K | 0.02% |
800
| – | – |
|
239
Centrus Energy
LEU
$3.74B
| $38.6K | 0.02% |
1,200
| – | – |
|
|
DMTK
240
DELISTED
DermTech, Inc. Common Stock
DMTK
| $38.6K | 0.02% |
10,500
| – | – |
|
241
Capital One
COF
$142B
| $38.5K | 0.02% |
+400
| New | +$38.5K |
|
242
Atara Biotherapeutics
ATRA
$90.7M
| $38K | 0.02% |
524
| – | – |
|
243
Cooper Companies
COO
$13.5B
| $37.7K | 0.02% |
404
+4
| +1% | +$373 |
|
244
Oportun Financial
OPRT
$289M
| $36.7K | 0.02% |
9,500
| – | – |
|
245
Synchrony
SYF
$28.1B
| $36.6K | 0.02% |
1,257
+57
| +5% | +$1.66K |
|
|
GHL
246
DELISTED
Greenhill & Co., Inc.
GHL
| $36.4K | 0.02% |
4,100
| – | – |
|
247
CoreCard
CCRD
$212M
| $36.2K | 0.02% |
1,200
| – | – |
|
248
FS Bancorp
FSBW
$321M
| $36K | 0.02% |
+1,200
| New | +$36K |
|
249
Louisiana-Pacific
LPX
$6.9B
| $35.8K | 0.01% |
660
+144
| +28% | +$7.81K |
|
250
Nexstar Media Group
NXST
$6.31B
| $35.7K | 0.01% |
207
+107
| +107% | +$18.5K |
|